Malaysian (KLSE) Pharma Industry Analysis
UpdatedApr 12, 2024
DataAggregated Company Financials
Companies6
- 7D-0.2%
- 3M5.0%
- 1Y-4.8%
- YTDn/a
Over the last 7 days, the Pharma industry has remained flat. As for the longer term, the industry has declined 5.2% in the last year. In the next few years, earnings are forecast to decline by 19% annually.
Industry Valuation and Performance
Has the Malaysian Pharma Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Sat, 13 Apr 2024 | RM4.6b | RM2.6b | RM559.3m | 12.3x | 8.1x | 1.7x |
| Mon, 11 Mar 2024 | RM4.5b | RM2.6b | RM559.3m | 12.6x | 8x | 1.7x |
| Wed, 07 Feb 2024 | RM4.5b | RM2.6b | RM584.9m | 12.2x | 7.7x | 1.8x |
| Fri, 05 Jan 2024 | RM4.3b | RM2.6b | RM584.9m | 12.5x | 7.4x | 1.7x |
| Sun, 03 Dec 2023 | RM4.2b | RM2.6b | RM584.9m | 12.1x | 7.1x | 1.6x |
| Tue, 31 Oct 2023 | RM4.2b | RM2.6b | RM604.4m | 11.9x | 7x | 1.6x |
| Thu, 28 Sep 2023 | RM4.3b | RM2.6b | RM604.4m | 12.6x | 7.1x | 1.7x |
| Sat, 26 Aug 2023 | RM4.3b | RM2.6b | RM604.6m | 12.5x | 7.2x | 1.7x |
| Mon, 24 Jul 2023 | RM4.4b | RM2.6b | RM304.7m | 14.4x | 14.3x | 1.7x |
| Wed, 21 Jun 2023 | RM4.4b | RM2.6b | RM304.7m | 14.2x | 14.5x | 1.7x |
| Fri, 19 May 2023 | RM4.7b | RM2.5b | RM289.5m | 13.4x | 16.4x | 1.9x |
| Sun, 16 Apr 2023 | RM4.8b | RM2.5b | RM289.8m | 13.4x | 16.4x | 1.9x |
| Tue, 14 Mar 2023 | RM4.7b | RM2.5b | RM289.8m | 13.5x | 16.2x | 1.9x |
| Thu, 09 Feb 2023 | RM4.5b | RM2.4b | RM270.7m | 13.1x | 16.8x | 1.9x |
| Sat, 07 Jan 2023 | RM4.7b | RM2.4b | RM270.7m | 12.9x | 17.5x | 1.9x |
| Mon, 05 Dec 2022 | RM4.4b | RM2.4b | RM270.7m | 12.5x | 16.4x | 1.8x |
| Wed, 02 Nov 2022 | RM4.1b | RM2.4b | RM249.0m | 11.9x | 16.4x | 1.7x |
| Fri, 30 Sep 2022 | RM3.9b | RM2.4b | RM249.0m | 11.7x | 15.6x | 1.6x |
| Sun, 28 Aug 2022 | RM3.9b | RM2.4b | RM245.2m | 11.9x | 16.1x | 1.7x |
| Tue, 26 Jul 2022 | RM3.8b | RM2.3b | RM226.0m | 14x | 17x | 1.7x |
| Thu, 23 Jun 2022 | RM3.4b | RM2.3b | RM226.0m | 13.8x | 15.1x | 1.5x |
| Sat, 21 May 2022 | RM4.0b | RM2.3b | RM211.5m | 16.1x | 18.8x | 1.7x |
| Mon, 18 Apr 2022 | RM4.0b | RM2.2b | RM204.5m | 16.5x | 19.8x | 1.8x |
| Wed, 16 Mar 2022 | RM3.7b | RM2.2b | RM204.5m | 15.7x | 17.9x | 1.6x |
| Fri, 11 Feb 2022 | RM3.8b | RM2.1b | RM187.4m | 16.1x | 20.4x | 1.8x |
| Sun, 09 Jan 2022 | RM3.7b | RM2.1b | RM187.4m | 15.7x | 19.9x | 1.7x |
| Tue, 07 Dec 2021 | RM3.7b | RM2.1b | RM187.4m | 14.8x | 19.6x | 1.7x |
| Thu, 04 Nov 2021 | RM3.7b | RM2.0b | RM166.6m | 20.3x | 22.4x | 1.8x |
| Sat, 02 Oct 2021 | RM3.9b | RM2.0b | RM166.6m | 21x | 23.7x | 2x |
| Mon, 30 Aug 2021 | RM4.0b | RM2.0b | RM166.5m | 19.8x | 24.1x | 2x |
| Tue, 06 Jul 2021 | RM4.5b | RM2.0b | RM166.5m | 20.2x | 26.9x | 2.2x |
Price to Earnings Ratio
25.5x
Current Industry PE
- Investors are pessimistic on the Malaysian Pharmaceuticals industry, indicating that they anticipate long term growth rates will be lower than they have historically.
- The industry is trading at a PE ratio of 8.1x which is lower than its 3-year average PE of 16.5x.
- The industry is trading close to its 3-year average PS ratio of 1.8x.
Past Earnings Growth
- The earnings for companies in the Pharmaceuticals industry have grown 50% per year over the last three years.
- Revenues for these companies have grown 10% per year.
- This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too.
Industry Comparison
How does Malaysian Pharma compare with similar industries?
| MY Market | 0.25% | |
| Healthcare | 0.20% | |
| Pharma | -0.22% | |
| Pharma | -0.22% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| AHEALTH Apex Healthcare Berhad | RM3.04 | 1.7% +RM35.9m | 11.8% | PE5.5x |